Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
Chu VT, Weber T, Graf R, Sommermann T, Petsch K, Sack U, Volchkov P, Rajewsky K, Kühn R. · 2016
Read Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes. by Chu VT, Weber T, Graf R, Sommermann T, Petsch K, Sack U, Volchkov P, Rajewsky K, Kühn R. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4715285.txt.
Introduction
Van Trung Chu, Timm Weber, Robin Graf, and six colleagues used CRISPR editing to place large inserts into mouse embryos, in BMC Biotechnology in 2016. The Rosa26 site in the mouse genome is a safe harbor where added genes can sit and work everywhere. Building such knock-in mice the classic way, through stem cells, takes the better part of a year. The team instead injected CRISPR parts straight into fertilized eggs of the standard laboratory strain, aiming inserts of eight to eleven thousand bases at Rosa26.
Between a tenth and a fifth of live-born pups carried the desired edit, with no apparent off-target damage, and Cas9 protein raised embryo success further. One product was a new mouse line that switches on Cas9 where a second signal directs. The protocols promise fast, direct construction of knock-in mice in the strain researchers use most, skipping the stem-cell detour.
Catalog record
| CREATOR | Chu VT, Weber T, Graf R, Sommermann T, Petsch K, Sack U, Volchkov P, Rajewsky K, Kühn R. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes By Van Trung Chu, Timm Weber, Robin Graf, Thomas Sommermann, Kerstin Petsch, Ulrike Sack, Pavel Volchkov, Klaus Rajewsky, Ralf Kühn Published in: BMC Biotechnology DOI: 10.1186/s12896-016-0234-4 ABSTRACT Background The CRISPR/Cas9 system is increasingly used for gene inactivation in mouse zygotes, but homology-directed mutagenesis and use of inbred embryos are less established. In particular, Rosa26 knock-in alleles for the insertion of transgenes in a genomic ‘safe harbor’ site, have not been produced. Here we applied CRISPR/Cas9 for the knock-in of 8–11 kb inserts into Rosa26 of C57BL/6 zygotes. Results We found that 10–20 % of live pups derived from microinjected zygotes were founder mutants, without apparent off-target effects, and up to 50 % knock-in embryos were recovered upon coinjection of Cas9 mRNA and protein. Using this approach, we established a new mouse line for the Cre/loxP-dependent expression of Cas9. Conclusions Altogether, our protocols and resources support the fast and direct generation of new Rosa26 knock-in alleles and of Cas9-mediated in vivo gene editing in the widely used C57BL/6 inbred strain. Electronic supplementary material The online version of this article (doi:10.1186/s12896-016-0234-4) contains supplementary material, which is available to authorized users. BACKGROUND The Rosa26 locus on chromosome 6 is frequently used for the integration of transgene constructs to achieve ubiquitous or conditional gene expression in mice. The Rosa26 transcript is spliced into three exons and ubiquitously expressed in all cell types and developmental stages, but not translated to a protein [1]. The locus was first identified by the integration of the Rosaβ-geo (reverse orientation splice acceptor βGal) gene trap vector in pool #26 of transduced embryonic stem (ES) cells [2]. This integration site, residing at the XbaI site within the first intron of Rosa26, has been used for ES-based gene targeting from its discovery on. A Rosa26 targeting vector is extending 1 kb upstream and 4 kb downstream from the integration site within the first intron, flanking transgene inserts [3]. In the classical gene targeting procedure, targeted ES cell clones are injected into blastocysts to obtain germline chimeric mice and the transmission of targeted alleles to their offspring. This approach requires laborious handling of ES cell cultures and waiting times of 9–12 months until identification of positive F1 pups [4]. Nevertheless, the Rosa26 locus is frequently targeted via ES cells for inserting single transgene copies in a standardized configuration into the mouse genome. The Mouse Genome Informatics database (MGI, www.informatics.jax.org) refers to 562 Rosa26 knock-in mouse strains that have been generated for probing the effects of constitutively or conditionally expressed mutant proteins or for the imaging of reporter genes in vivo. Rosa26 knock-in alleles are often configured such that coding regions are expressed under the control of the CAG hybrid promoter [5] or they are connected with splice acceptor elements to the endogenous Rosa26 transcript [3]. Conditional gene expression is achieved by insertion of a loxP-flanked transcriptional stop element between the promoter and coding regions. In such a case, gene expression is induced by crossing the conditional knock-in line with transgenic mice expressing Cre recombinase in specific cell types [6]. Double-strand breaks (DSB) induced by engineered nucleases in mouse zygotes have emerged as powerful tool for the direct, single step production of targeted mutants, independent of ES cells. Proof of principle was provided with Zinc-finger nucleases and TALENs [7, 8], both of which have been largely displaced by the more versatile and efficient CRISPR/Cas9 gene editing system [9]. This system is composed of the generic Cas9 nuclease that is guided to specific target sites by short sgRNAs including 20 nucleotides complementary to the target sequence upstream of a PAM signal (NGG). Gene editing is achieved by endogenous DSB repair pathways, either imprecisely by non-homologous end joining (NHEJ) causing small deletions, or by homology-directed repair (HDR) using repair template vectors for the precise insertion of new sequences. In mouse zygotes, CRISPR/Cas9 has been efficiently used for generating small deletions and knockout mutations by the NHEJ repair pathway, reaching frequencies of 50 % in pups derived from RNA microinjections [10, 11], even in inbred backgrounds such as C57BL/6. In contrast, HDR events with co-injected targeting vectors occur rarely in zygotes. A limited number of studies reported the generation of knock-in alleles at frequencies of 5–15 % for a small number of genes [11, 12], not targeting Rosa26 and using genetic hybrid embryos known for superior viability. Thus, an approach for the direct production of Rosa26 knock-in alleles in C57BL/6 embryos is presently not established, despite this inbred background being a standard in biomedical research. Here we applied CRISPR/Cas9 for the knock-in of conditional transgenes into Rosa26 of C57BL/6 zygotes. Using modified Cas9 mRNA and sgRNA targeting the intronic XbaI site of Rosa26, compatible with common targeting vector homology regions, we achieved the knock-in of 8–11 kb inserts in 10–20 % of pups derived from microinjections of C57BL/6 embryos. This frequency increased to 50 % upon the combined microinjection of Cas9 mRNA and Cas9 protein, as tested in blastocyst assays. In addition to editing of the mouse germ line in zygotes, CRISPR/Cas9 offers a new perspective for modifying gene function in somatic tissues. To avoid the vector-mediated delivery of the large Cas9 transgene into primary cells, we generated Rosa26 knock-in mice for the Cre/loxP-dependent expression of Cas9. Taken together, our protocols and resources support the fast and direct generation of new Rosa26 knock-in alleles and of Cas9-mediated in vivo gene editing in the C57BL/6 background. RESULTS Efficient DSBs induction at the Rosa26 intronic XbaI site in C57BL/6 zygotes To achieve CRISPR/Cas9-mediated knock-in into Rosa26, we selected sgRNA target sequences spanning the XbaI site within the first intron, adapted to the homology regions of gene targeting vectors used for ES cells that cover sequences up- and downstream of this site [3]. As we have shown previously, sgRosa26-1 (Fig. 1a) exhibits high activity in mouse cells [13]. We therefore selected sgRosa26-1, together with a Cas9 mRNA that includes a plasmid coded polyadenine (polyA) tail (Cas9-162A) [14], for targeting in zygotes. The most effective concentrations of Cas9-162A and sgRosa26-1 RNAs were determined by microinjection of varying amounts of RNA into the pronuclei of C57BL/6 zygotes, followed by embryo culture to the blastocyst stage. Genomic DNA was extracted from each blastocyst and used for PCR amplification of the target region (Fig. 1b). PCR products were analyzed for NHEJ repair-associated deletions by digestion with XbaI or the T7 endonuclease I (T7EI). At the lowest concentrations of Cas9-162A (5 ng/μl) and sgRosa26-1 (2.5 ng/μl) RNAs, Rosa26 alleles from 40 % of the embryos exhibited sequence deletions, as shown by the presence of XbaI resistant bands, whereas T7EI assays were less sensitive (Fig. 1c). Sequencing of cloned PCR products from four blastocysts confirmed the presence of small deletions at the expected cleavage site. Of note, individual deletion events could generate new XbaI sites, causing an underestimation of gene editing events by XbaI digestion (Fig. 1d). Upon RNA microinjection of Cas9-162A at 25 ng/μl and sgRosa26-1 at 12.5 ng/μl, 80 % of cultured embryos showed XbaI resistant PCR products, a percentage that was not further increased at higher concentrations (Fig. 1e, Additional file 1: Figure S1). XbaI resistant PCR products represented a minor